Manufacturing Highly Potent Cytotoxic, Anticancer and Oncology Drugs
With an increasing emphasis on both operator safety and product protection, the commercial-scale production of oncology drugs, hormonal products and/or other highly potent compounds has been put under the pharmaceutical spotlight in recent years.
Eliminating the need for cumbersome isolation suits to prevent operators being exposed to hazardous substance and avoid cross-contamination with other products manufactured in the same facility, GEA’s approach is to use containment interfaces (the BUCK® MC high-containment range and disposable Hicoflex® products) to ensure compliance with global regulatory cGMP requirements.
Experts in contained material handling, closed product processing, gentle product treatment, the efficient recovery of active ingredients and reliable scale-up, we supply modules, components and fully integrated batch and continuous lines for the production of oncology drugs and other therapeutic agents that deliver increased yields and reduced cycle times.
From R&D-scale and standalone production equipment to contained production lines, we understand the absolute importance of preventing cross-contamination in the production area, protecting both people and products, and working within Real Daily Intake (RDI) and Acceptable Daily Intake (ADI) limits with up to occupational exposure band (OEB) 5 drugs.
GEA has a wealth of expertise and an unparalleled depth of experience in the field of containment. The company not only offers a comprehensive range of robust and compliant containment products, it also boasts unrivaled experience in identifying the most appropriate solution and a thorough understanding of containment risk analysis.
Produtos e Tecnologias
Mostrando 4 de 26
Automação de Processo
Como integradores de sistema, trazemos nosso conhecimento de tecnologia de processo e engenharia de planta, juntamente com produtos de software de líderes de mercado.
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Downloads
Insights da GEA
Engarrafando os benefícios: a engenharia por trás das bebidas funcionais
À medida que a demanda dos consumidores por bebidas de última geração que promovam a saúde e o bem-estar continua a evoluir e crescer, a GEA ajuda os fabricantes a lançar novos produtos no mercado com segurança, eficiência e em grande escala.
Innovating for impact: criando melhores soluções para os clientes
Há a exigência de que a produção industrial utilize menos recursos, se torne mais eficiente e mantenha os equipamentos produtivos por mais tempo. Na GEA, isso está mudando a forma como a inovação ocorre: engenharia, conhecimento do cliente, expertise digital e serviços se unem em um estágio mais precoce – quando ainda é possível moldar a essência de uma solução.
